FDA and representatives of the generic drug industry meet bi-annually to discuss current and emerging regulatory science challenges and concerns. Minutes from these meetings are posted on this page.
FDA – Industry Regulatory Science Work Group Meeting FY 2023
FDA – Industry Regulatory Science Work Group Meeting FY 2022
FDA – Industry Regulatory Science Work Group Meeting FY 2021
FDA – Industry Regulatory Science Work Group Meeting FY 2020
FDA – Industry Regulatory Science Work Group Meetings FY 2019
FDA – Industry Regulatory Science Work Group Meetings FY 2018
-
Content current as of:
08/30/2024
